Radiation oncology enters the era of individualised medicine

Affiliations

¹ Department of Radiation Oncology, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands. Electronic address: philip.poortmans@radboudumc.nl.
² Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA.
³ Department of Radiation Oncology, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands.

Comment

Philip Poortmans et al. Lancet Oncol. 2017 Feb.

. 2017 Feb;18(2):159-160.

doi: 10.1016/S1470-2045(16)30660-X. Epub 2016 Dec 18.

¹ Department of Radiation Oncology, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands. Electronic address: philip.poortmans@radboudumc.nl.
² Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA.
³ Department of Radiation Oncology, Radboud University Medical Center, 6500 HB Nijmegen, Netherlands.

No abstract available

Comment on

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS, Mellon E, Venkat P, Johnstone P, Foekens J, Lee J, Moros E, Dalton WS, Eschrich SA, McLeod H, Harrison LB, Torres-Roca JF. Scott JG, et al. Lancet Oncol. 2017 Feb;18(2):202-211. doi: 10.1016/S1470-2045(16)30648-9. Epub 2016 Dec 18. Lancet Oncol. 2017. PMID: 27993569 Free PMC article.